Financial News · Live Terminal

Page 451 of 538

AbbVie to Make $18 Million Milestone Payment to EvolveImmune Therapeutics After Nomination of Development Candidate

AbbVie (ABBV) partner EvolveImmune Therapeutics has nominated a development candidate for a next-generation cancer biotherapeutic, triggering a preclinical milestone payment of $18 million from AbbVie, the immuno-oncology company said Tuesday.The two companies entered into a collaboration and option-to-license agreement to develop multi-specific biologics for multiple targets in oncology in October 2024, according to a statement.Price: $198.10, Change: $+0.72, Percent Change: +0.37%

Financial News · Live Terminal

AbbVie to Make $18 Million Milestone Payment to EvolveImmune Therapeutics After Nomination of Development Candidate

Street Color: Walt Disney's Broadcast Licenses to Be Reviewed by US Federal Communications Commission, Semafor Reports

Mizuho Securities Adjusts Axsome Therapeutics Price Target to $228 From $230, Maintains Outperform Rating

Update: Kiniksa Pharmaceuticals Q1 Earnings, Revenue Rise; 2026 Arcalyst Revenue Outlook Raised

First Financial Q1 Shares Rise After Posting Higher Q1 Net Income, Revenue

Morgan Stanley Adjusts Regency Centers PT to $88 From $85, Maintains Overweight Rating

Morgan Stanley Adjusts MetLife Price Target to $89 From $93, Maintains Overweight Rating

Morgan Stanley Adjusts Seagate Technology PT to $582 From $468, Maintains Overweight Rating

Morgan Stanley Adjusts ConocoPhillips Price Target to $149 From $108, Maintains Overweight Rating

T-Mobile US to Form Two JVs to Expand Fiber Footprint

Sportradar Names Sameer Deen COO

Gen, xAI Team Up to Integrate AI Models Into Consumer Platforms

AbbVie Submits Application for Upadacitinib as Alopecia Areata Treatment to FDA

Morgan Stanley Adjusts Public Service Enterprise Price Target to $94 From $90, Maintains Overweight Rating

Honeywell International Sets June 29 Target for Aerospace Spin-Off Completion

Morgan Stanley Lifts Old Dominion Freight Line Price Target to $215 From $209, Maintains Overweight Rating

Morgan Stanley Adjusts Devon Energy Price Target to $59 From $46, Maintains Overweight Rating

Morgan Stanley Adjusts FirstEnergy Price Target to $54 From $53, Maintains Overweight Rating

JPMorgan Chase Chosen as First Global Banking Partner of Olympic Games

Morgan Stanley Adjusts Price Target on Paychex to $107 From $123, Maintains Equalweight Rating

AbbVie to Make $18 Million Milestone Payment to EvolveImmune Therapeutics After Nomination of Development Candidate

Street Color: Walt Disney's Broadcast Licenses to Be Reviewed by US Federal Communications Commission, Semafor Reports

Mizuho Securities Adjusts Axsome Therapeutics Price Target to $228 From $230, Maintains Outperform Rating

Update: Kiniksa Pharmaceuticals Q1 Earnings, Revenue Rise; 2026 Arcalyst Revenue Outlook Raised

First Financial Q1 Shares Rise After Posting Higher Q1 Net Income, Revenue

Morgan Stanley Adjusts Regency Centers PT to $88 From $85, Maintains Overweight Rating

Morgan Stanley Adjusts MetLife Price Target to $89 From $93, Maintains Overweight Rating

Morgan Stanley Adjusts Seagate Technology PT to $582 From $468, Maintains Overweight Rating

Morgan Stanley Adjusts ConocoPhillips Price Target to $149 From $108, Maintains Overweight Rating

T-Mobile US to Form Two JVs to Expand Fiber Footprint

Sportradar Names Sameer Deen COO

Gen, xAI Team Up to Integrate AI Models Into Consumer Platforms

AbbVie Submits Application for Upadacitinib as Alopecia Areata Treatment to FDA

Morgan Stanley Adjusts Public Service Enterprise Price Target to $94 From $90, Maintains Overweight Rating

Honeywell International Sets June 29 Target for Aerospace Spin-Off Completion

Morgan Stanley Lifts Old Dominion Freight Line Price Target to $215 From $209, Maintains Overweight Rating

Morgan Stanley Adjusts Devon Energy Price Target to $59 From $46, Maintains Overweight Rating

Morgan Stanley Adjusts FirstEnergy Price Target to $54 From $53, Maintains Overweight Rating

JPMorgan Chase Chosen as First Global Banking Partner of Olympic Games

Morgan Stanley Adjusts Price Target on Paychex to $107 From $123, Maintains Equalweight Rating